Han OP - Search Results

1

Incidence of diarrhea caused by rotavirus infections in rural Zhengding, China: prospective, population-based surveillance.

Wang XY, Xu ZY, von Seidlein L, Zhang YL, Zhao SJ, Hao ZY, Han OP, Kilgore P, Xing ZC, Han CQ, Ma JC, Chen JC, Clemens J. Wang XY, et al. Among authors: han op. J Infect Dis. 2005 Sep 1;192 Suppl 1:S100-5. doi: 10.1086/431507. J Infect Dis. 2005. PMID: 16088791

2

Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study.

Wang XY, Du L, Von Seidlein L, Xu ZY, Zhang YL, Hao ZY, Han OP, Ma JC, Lee HJ, Ali M, Han CQ, Xing ZC, Chen JC, Clemens J. Wang XY, et al. Among authors: han op. Am J Trop Med Hyg. 2005 Aug;73(2):416-22. Am J Trop Med Hyg. 2005. PMID: 16103614

3

Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up.

Wang XY, Xu ZY, Ma JC, von Seidlein L, Zhang Y, Hao ZY, Han OP, Zhang YL, Tian MY, Ouyang PY, Zhang ZY, Han CQ, Xing ZC, Chen JC. Wang XY, et al. Among authors: han op. Vaccine. 2007 Jan 5;25(3):446-9. doi: 10.1016/j.vaccine.2006.08.004. Epub 2006 Aug 17. Vaccine. 2007. PMID: 16949710 Clinical Trial.

4

The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance.

Agtini MD, Soeharno R, Lesmana M, Punjabi NH, Simanjuntak C, Wangsasaputra F, Nurdin D, Pulungsih SP, Rofiq A, Santoso H, Pujarwoto H, Sjahrurachman A, Sudarmono P, von Seidlein L, Deen JL, Ali M, Lee H, Kim DR, Han O, Park JK, Suwandono A, Ingerani, Oyofo BA, Campbell JR, Beecham HJ, Corwin AL, Clemens JD. Agtini MD, et al. BMC Infect Dis. 2005 Oct 20;5:89. doi: 10.1186/1471-2334-5-89. BMC Infect Dis. 2005. PMID: 16242013 Free PMC article.

5

Health care preferences for children with typhoid fever in two slum communities in Karachi, Pakistan.

Memon ZA, Pach A, Rifkin M, Han OP, Stanton B, Clemens J, Bhutta Z. Memon ZA, et al. Among authors: han op. Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):1110-25. Southeast Asian J Trop Med Public Health. 2008. PMID: 19062704

6

Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform.

Agtini MD, Ochiai RL, Soeharno R, Lee HJ, Sundoro J, Hadinegoro SR, Han OP, Tana L, Halim FX, Ghani L, Delima, Lestari W, Sintawati FX, Kusumawardani N, Malik R, Santoso TS, Nadjib M, Soeroso S, Wangsasaputra F, Ali M, Ivanoff B, Galindo CM, Pang T, Clemens JD, Suwandono A, Acosta CJ. Agtini MD, et al. Among authors: han op. Public Health. 2006 Nov;120(11):1081-7. doi: 10.1016/j.puhe.2006.06.008. Epub 2006 Sep 26. Public Health. 2006. PMID: 17005220

7

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.

Pratley RE, Kang J, Trautmann ME, Hompesch M, Han O, Stewart J, Sorli CH, Jacob S, Yoon KH. Pratley RE, et al. Diabetes Obes Metab. 2019 Nov;21(11):2429-2439. doi: 10.1111/dom.13824. Epub 2019 Aug 13. Diabetes Obes Metab. 2019. PMID: 31264757 Free PMC article. Clinical Trial.

8

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.

Hompesch M, Kang J, Han O, Trautmann ME, Sorli CH, Ogbaa I, Stewart J, Morrow L. Hompesch M, et al. BMJ Open Diabetes Res Care. 2021 Jun;9(1):e002208. doi: 10.1136/bmjdrc-2021-002208. BMJ Open Diabetes Res Care. 2021. PMID: 34172436 Free PMC article. Clinical Trial.

9

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.

Pratley RE, Jacob S, Baek S, Trautmann ME, Hompesch M, Han O, Stewart J, Sorli CH, Shaunik A, Yoon KH. Pratley RE, et al. BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002207. doi: 10.1136/bmjdrc-2021-002207. BMJ Open Diabetes Res Care. 2022. PMID: 35042751 Free PMC article. Clinical Trial.

10

Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial.

Kim DW, Lee DH, Han JY, Lee J, Cho BC, Kang JH, Lee KH, Cho EK, Kim JS, Min YJ, Cho JY, An HJ, Kim HG, Lee KH, Kim BS, Jang IJ, Yoon S, Han O, Noh YS, Hong KY, Park K. Kim DW, et al. Lung Cancer. 2019 Sep;135:66-72. doi: 10.1016/j.lungcan.2019.07.007. Epub 2019 Jul 9. Lung Cancer. 2019. PMID: 31447004 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters